The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 10515869)

Published in Blood on October 15, 1999

Authors

G Berrozpe1, I Timokhina, S Yukl, Y Tajima, M Ono, A D Zelenetz, P Besmer

Author Affiliations

1: Molecular Biology Program Sloan-Kettering Institute, New York, NY, USA.

Articles citing this

Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol (2005) 3.88

Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus. Mol Cell (2008) 3.24

Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy (2005) 2.32

Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02

Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol (2008) 1.93

Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med (2007) 1.68

Retracted Iron supplementation decreases severity of allergic inflammation in murine lung. PLoS One (2012) 1.55

A distant upstream locus control region is critical for expression of the Kit receptor gene in mast cells. Mol Cell Biol (2006) 1.20

Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med (2013) 1.14

The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation (2011) 1.12

Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med (2006) 1.12

Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS One (2010) 0.99

Mast cells and metabolic syndrome. Biochim Biophys Acta (2010) 0.95

Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment. Int Immunopharmacol (2008) 0.91

Alopecia in IL-10-deficient mouse pups is c-kit-dependent and can be triggered by iron deficiency. Exp Dermatol (2010) 0.91

The Skin-Resident Immune Network. Curr Dermatol Rep (2013) 0.87

Mast cells rescue implantation defects caused by c-kit deficiency. Cell Death Dis (2013) 0.85

S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms. Br J Pharmacol (2015) 0.80

KIT is required for hepatic function during mouse post-natal development. BMC Dev Biol (2007) 0.79

Green fluorescent protein transgene driven by Kit regulatory sequences is expressed in hematopoietic stem cells. Haematologica (2009) 0.78

Mast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam. PLoS One (2011) 0.78

Disruption of c-Kit Signaling in Kit(W-sh/W-sh) Growing Mice Increases Bone Turnover. Sci Rep (2016) 0.75

Articles by these authors

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell (1996) 7.69

The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature (1988) 6.35

gltB gene and regulation of nitrogen metabolism by glutamine synthetase in Escherichia coli. J Bacteriol (1978) 5.59

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature (1996) 5.25

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev (1999) 5.13

Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J (1990) 5.08

The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell (1990) 4.91

A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (1986) 4.90

Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J (1988) 3.89

Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol (1986) 3.52

Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol (1996) 3.40

Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. Genes Dev (1989) 3.29

Molecular cloning and characterization of the chicken gene homologous to the transforming gene of Rous sarcoma virus. Cell (1981) 3.26

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol (1997) 3.02

A conditional lethal mutation in an Escherichia coli strain with a longer chemical lifetime of messenger RNA. J Mol Biol (1979) 2.87

Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol (1999) 2.77

Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J Virol (1973) 2.75

The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science (1990) 2.75

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71

Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer (2000) 2.64

Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases. Cancer (1998) 2.31

Sequence organization of cloned intracisternal A particle genes. Cell (1980) 2.27

Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J Virol (1986) 2.25

Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med (1999) 2.23

Gonadal expression of c-kit encoded at the W locus of the mouse. Development (1990) 2.21

Nucleotide sequence of the Syrian hamster intracisternal A-particle gene: close evolutionary relationship of type A particle gene to types B and D oncovirus genes. J Virol (1985) 2.20

Transformation of NIH/3T3 mouse cells by DNA of Rous sarcoma virus. Cell (1979) 2.17

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol (2007) 2.17

Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses. EMBO J (2000) 2.13

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model. Blood (2001) 2.08

Mechanism of restriction of ecotropic and xenotropic murine leukemia viruses and formation of pseudotypes between the two viruses. J Virol (1977) 2.08

Diagnosis and management of heterotopic pancreas. Int Surg (1993) 2.04

Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci U S A (1994) 2.02

Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell (1992) 2.01

Virus-like 30S RNA in mouse cells. J Virol (1979) 1.99

Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J (1990) 1.94

Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res (1999) 1.93

Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med (1999) 1.92

Respiratory health associated with exposure to automobile exhaust. I. Results of cross-sectional studies in 1979, 1982, and 1983. Arch Environ Health (1993) 1.92

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Ann Oncol (2006) 1.91

Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 1. General introduction. J Biol Chem (1976) 1.91

Gene affecting longevity of messenger RNA: a mutant of Escherichia coli with altered mRNA stability. Mol Gen Genet (1977) 1.90

Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol (1998) 1.89

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene (1997) 1.88

Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes (2000) 1.86

Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J (1998) 1.83

Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem (1996) 1.81

Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res (1995) 1.76

Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol (1987) 1.75

Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol (1995) 1.73

Mechanism of induction of RNA tumor viruses by halogenated pyrimidines. Cold Spring Harb Symp Quant Biol (1975) 1.71

W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development (1993) 1.70

Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.63

Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand (2000) 1.61

Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol (1992) 1.61

Determination of Wolbachia genome size by pulsed-field gel electrophoresis. J Bacteriol (2001) 1.60

Studies on polynucleotides. CXVII. Hybridization of polydeoxynucleotides with tyrosine transfer RNA sequences to the r-strand of phi80psu + 3 DNA. J Mol Biol (1972) 1.58

Long terminal repeat sequences of intracisternal A particle genes in the Syrian hamster genome: identification of tRNAPhe as a putative primer tRNA. Nucleic Acids Res (1983) 1.57

Terminally redundant sequences in cellular intracisternal A-particle genes. J Virol (1981) 1.57

Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med (1999) 1.56

Transformation by subgenomic fragments of Rous sarcoma virus DNA. Cell (1980) 1.56

Interaction of the erythropoietin and stem-cell-factor receptors. Nature (1995) 1.55

Mutual homology of mouse immunoglobulin gamma-chain gene sequences. Biochemistry (1979) 1.55

Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol (1999) 1.54

Three different types of dry eye syndrome. Cornea (1994) 1.53

The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chem Biol (2000) 1.52

The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc Natl Acad Sci U S A (1995) 1.52

Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology (1998) 1.49

Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J (1995) 1.48

c-kit protein, a transmembrane kinase: identification in tissues and characterization. Mol Cell Biol (1988) 1.47

Differential diagnosis between thymoma and non-thymoma by dynamic MR imaging. Acta Radiol (2002) 1.46

Oriental orchid (Cymbidium pumilum) attracts drones of the Japanese honeybee (Apis cerana japonica) as pollinators. Experientia (1991) 1.44

A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerative colitis. Intern Med (1997) 1.43

Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res (1995) 1.43

Cloning, sequence analysis, and expression of alteration of the mRNA stability gene (ams+) of Escherichia coli. J Bacteriol (1985) 1.43

Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol (1996) 1.42

Assignment of the receptor for ecotropic murine leukemia virus to mouse chromosome 5. J Exp Med (1978) 1.42

Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med (1994) 1.41

Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J Exp Med (1998) 1.41

Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood (1991) 1.40

The differential actions of cortisol on the accumulation of alpha-lactalbumin and casein in midpregnant mouse mammary gland in culture. Cell (1980) 1.39

Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med (2000) 1.39

High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice. Proc Natl Acad Sci U S A (1981) 1.38

MR findings of surgically retained sponges and towels: report of two cases. Radiat Med (1993) 1.37

Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest (2000) 1.35

Genetic analysis of mutations affecting ribonuclease II in Escherichia coli. Mol Gen Genet (1977) 1.34

Cerebellar arteries originating from the internal carotid artery. AJNR Am J Neuroradiol (1993) 1.34

Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res (1996) 1.33

The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia. Dev Biol (1993) 1.31

A HindIII RFLP demonstrated for the kit oncogene on chromosome 4. Nucleic Acids Res (1988) 1.31

Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun (1987) 1.31

The mouse W/c-kit locus. Ciba Found Symp (1990) 1.30

Sodium bicarbonate in seminal plasma stimulates the motility of mammalian spermatozoa through direct activation of adenylate cyclase. J Biol Chem (1985) 1.30

Consequences of exclusive expression in vivo of Kit-ligand lacking the major proteolytic cleavage site. Proc Natl Acad Sci U S A (1998) 1.28